BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9794120)

  • 21. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
    Opaleye OO; Igboama MC; Ojo JA; Odewale G
    J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
    Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
    J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.
    Cacoub P; Renou C; Rosenthal E; Cohen P; Loury I; Loustaud-Ratti V; Yamamoto AM; Camproux AC; Hausfater P; Musset L; Veyssier P; Raguin G; Piette JC
    Medicine (Baltimore); 2000 Jan; 79(1):47-56. PubMed ID: 10670409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kala-azar patients in Delhi.
    Singh S; Dwivedi SN; Sood R; Wali JP
    Scand J Infect Dis; 2000; 32(1):3-6. PubMed ID: 10716069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
    Vaux S; Chevaliez S; Saboni L; Sauvage C; Sommen C; Barin F; Alexandre A; Jauffret-Roustide M; Lot F; Velter A;
    BMC Infect Dis; 2019 Apr; 19(1):315. PubMed ID: 30971207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France].
    Bruandet A; Lucidarme D; Decoster A; Ilef D; Harbonnier J; Jacob C; Delamare C; Cyran C; Van Hoenacker AF; Frémaux D; Josse P; Emmanuelli J; Le Strat Y; Filoche B; Desenclos JC
    Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S15-1S22. PubMed ID: 17073126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demographic factors influencing hepatitis B and C infection in Benghazi, Libyan Arab Jamahiriya].
    Kutrani H; El-Gatit A; Shekhteryea A; El-Gitait Y; Sudani O; Akoub S
    East Mediterr Health J; 2007; 13(1):85-97. PubMed ID: 17546910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of HCV antibody in 12 280 inpatients admitted not for infectious diseases].
    Wei D; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1125, 1129. PubMed ID: 15501734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.
    Pawlotsky JM; Bélec L; Grésenguet G; Deforges L; Bouvier M; Duval J; Dhumeaux D
    J Med Virol; 1995 Jul; 46(3):269-72. PubMed ID: 7561802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].
    Cifuentes C; Mira JA; Vargas J; Neukam K; Escassi C; García-Rey S; Gilabert I; González-Monclova M; Bernal S; Pineda JA
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):452-7. PubMed ID: 22541340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group.
    Dubois F; Desenclos JC; Mariotte N; Goudeau A
    Hepatology; 1997 Jun; 25(6):1490-6. PubMed ID: 9185773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HCV antibodies in hemodialyzed patients in Tunisia].
    Hmida S; Mojaat N; Chaouchi E; Mahjoub T; Khlass B; Abid S; Boukef K
    Pathol Biol (Paris); 1995 Sep; 43(7):581-3. PubMed ID: 8570261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence.
    Cazein F; Barin F; Le Strat Y; Pillonel J; Le Vu S; Lot F; Thierry D; Meffre C; Semaille C
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):e114-7. PubMed ID: 22772350
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study.
    Dussol B; Berthezène P; Brunet P; Roubicek C; Berland Y
    Am J Kidney Dis; 1995 Mar; 25(3):399-404. PubMed ID: 7532916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections with HBV, HCV and HIV in patients admitted to the neurosurgical department of a teaching hospital.
    Gańczak M; Szych Z
    Neurol Neurochir Pol; 2008; 42(3):231-7. PubMed ID: 18651329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.